Monday, October 28, 2013
Despite any evidence proving their safety, electronic cigarettes – or e-cigarettes – are a booming business in the United States. Clever marketing tactics have boosted the product’s image and appeal among users of different age groups, yet the technology remains unregulated by the US Food and Drug Administration.
Many health experts warn that without government regulation or standardization, it is impossible to lay any claim to their safety or efficacy as a smoking cessation product.
Memorial Sloan Kettering’s Jack Burkhalter is available to discuss the concerns he and others share about this increasingly popular trend. Dr. Burkhalter is a clinical health psychologist who focuses on smoking cessation and treatment of psychological distress in patients with lung cancer. He provides care to patients through Memorial Sloan Kettering’s Tobacco Cessation Program, where he works with smokers to quit and to avoid smoking in the future.
Additional BackgroundBack to top
For more information and to set up an interview, contact the Media Staff.Back to top